Published in J Biomater Sci Polym Ed on January 01, 1995
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials (2007) 1.67
Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol (2009) 1.46
Microsphere-based seamless scaffolds containing macroscopic gradients of encapsulated factors for tissue engineering. Tissue Eng Part C Methods (2008) 1.33
Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control. Biomaterials (2010) 1.04
Nanofiber-based delivery of bioactive agents and stem cells to bone sites. Adv Drug Deliv Rev (2012) 1.03
The effect of tri-calcium phosphate (TCP) addition on the degradation of polylactide-co-glycolide (PLGA). J Mater Sci Mater Med (2007) 0.99
Stem cell and biomaterials research in dental tissue engineering and regeneration. Dent Clin North Am (2012) 0.93
Sustained release of BMP-2 in bioprinted alginate for osteogenicity in mice and rats. PLoS One (2013) 0.92
Stimulation of healing within a rabbit calvarial defect by a PCL/PLGA scaffold blended with TCP using solid freeform fabrication technology. J Mater Sci Mater Med (2012) 0.91
Stem cell-mediated osteogenesis: therapeutic potential for bone tissue engineering. Biologics (2012) 0.86
Experimental and computational characterization of designed and fabricated 50:50 PLGA porous scaffolds for human trabecular bone applications. J Mater Sci Mater Med (2010) 0.85
A computer-designed scaffold for bone regeneration within cranial defect using human dental pulp stem cells. Sci Rep (2015) 0.85
Biodegradable CSMA/PECA/Graphene Porous Hybrid Scaffold for Cartilage Tissue Engineering. Sci Rep (2015) 0.85
Melt flow behaviour of poly-epsilon-caprolactone in fused deposition modelling. J Mater Sci Mater Med (2007) 0.82
2007 AIChE Alpha Chi Sigma Award: From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering. AIChE J (2008) 0.82
Microporous poly(L-lactic acid) membranes fabricated by polyethylene glycol solvent-cast/particulate leaching technique. Tissue Eng Part C Methods (2009) 0.80
Open-source three-dimensional printing of biodegradable polymer scaffolds for tissue engineering. J Biomed Mater Res A (2014) 0.80
Osteoblast behaviour on in situ photopolymerizable three-dimensional scaffolds based on D, L-lactide, epsilon-caprolactone and trimethylene carbonate. J Mater Sci Mater Med (2006) 0.80
Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin. J Mater Sci Mater Med (2010) 0.80
Founder's award to Antonios G. Mikos, Ph.D., 2011 Society for Biomaterials annual meeting and exposition, Orlando, Florida, April 13-16, 2011: Bones to biomaterials and back again--20 years of taking cues from nature to engineer synthetic polymer scaffolds. J Biomed Mater Res A (2011) 0.79
Supportive development of functional tissues for biomedical research using the MINUSHEET® perfusion system. Clin Transl Med (2012) 0.77
3D polylactide-based scaffolds for studying human hepatocarcinoma processes in vitro. Sci Technol Adv Mater (2012) 0.75
Synergistic Effect of Mesoporous Silica and Hydroxyapatite in Loaded Poly(DL-lactic-co-glycolic acid) Microspheres on the Regeneration of Bone Defects. Biomed Res Int (2016) 0.75
Bioactive polymeric scaffolds for tissue engineering. Bioact Mater (2016) 0.75
Osteoblast behaviour on in situ photopolymerizable three-dimensional scaffolds based on D,L-lactide and epsilon-caprolactone: influence of pore volume, pore size and pore shape. J Mater Sci Mater Med (2008) 0.75
Poly(ethylenimine) and its role in gene delivery. J Control Release (1999) 3.78
Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol (1975) 2.86
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A (1999) 2.81
Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol (2001) 2.43
Review: tissue engineering for regeneration of articular cartilage. Biomaterials (2000) 2.40
Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res (1999) 2.33
Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res (1997) 2.21
Effect of brain irradiation on demyelinating lesions. Neurology (1993) 2.21
Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials (2001) 1.94
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76
Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials (2000) 1.73
Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials (1998) 1.69
Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials (2001) 1.65
Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study. Arch Neurol (1996) 1.61
Reflex response of orbicularis oculi muscle to supraorbital nerve stimulation. Study in normal subjects and in peripheral facial paresis. Arch Neurol (1969) 1.55
Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res (2000) 1.50
A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis. Nature (1988) 1.46
Growth factor delivery for tissue engineering. Pharm Res (2000) 1.42
Nervous system involvement in type IV glycogenosis. Arch Pathol Lab Med (1979) 1.40
Biomaterials and bone mechanotransduction. Biomaterials (2001) 1.39
Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice. Eur J Neurosci (2004) 1.39
In vitro bond strength of two adhesives to enamel and dentin under normal and contaminated conditions. Dent Mater (1993) 1.36
A randomized prospective study of posterolateral lumbar fusion. Outcomes with and without pedicle screw instrumentation. Spine (Phila Pa 1976) (1999) 1.32
Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther (1999) 1.31
Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration. Biomaterials (1998) 1.30
In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. J Biomed Mater Res (1999) 1.30
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology (1977) 1.26
Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules (2001) 1.26
Cellular tropism and localization in the rodent nervous system of a neuropathogenic variant of Friend murine leukemia virus. Lab Invest (1992) 1.26
Polymer concepts in tissue engineering. J Biomed Mater Res (1998) 1.25
Growth factor-loaded scaffolds for bone engineering. J Control Release (2005) 1.25
In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials (1996) 1.24
Synthesis and properties of photocross-linked poly(propylene fumarate) scaffolds. J Biomater Sci Polym Ed (2001) 1.24
Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage (2006) 1.24
An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations. J Neuropathol Exp Neurol (1981) 1.22
Review: Hydrogels for cell immobilization. Biotechnol Bioeng (1996) 1.21
A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci U S A (1997) 1.20
Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J Cell Biochem (1998) 1.19
Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant (1994) 1.17
Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials (1998) 1.16
Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release (2005) 1.14
The importance of new processing techniques in tissue engineering. MRS Bull (1996) 1.14
Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies. Biomaterials (2004) 1.13
In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med (2006) 1.12
In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res (1998) 1.12
Biological activity of rhBMP-2 released from PLGA microspheres. J Biomech Eng (2000) 1.12
Bond strength of composite to porcelain treated with new porcelain repair agents. Dent Mater (1992) 1.12
Marrow stromal osteoblast function on a poly(propylene fumarate)/beta-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials (2000) 1.11
Adreno-leukodystrophy. Similar ultrastructural changes in adrenal cortical and Schwann cells. Arch Neurol (1974) 1.11
The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. Tissue Eng (1995) 1.11
Malignant rhabdoid tumor of the central nervous system. Hum Pathol (1987) 1.11
Growing new organs. Sci Am (1999) 1.10
A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology (1999) 1.10
In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials (1999) 1.10
Adreno-leukodystrophy (sex-linked Schilder's disease). A pathogenetic hypothesis based on ultrastructural lesions in adrenal cortex, peripheral nerve and testis. Am J Pathol (1974) 1.10
Adreno-leukodystrophy (sex-linked Schilder disease). Ultrastructural demonstration of specific cytoplasmic inclusions in the central nervous system. Arch Neurol (1974) 1.08
Crosslinking characteristics of an injectable poly(propylene fumarate)/beta-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res (1999) 1.07
Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed (2006) 1.06
Bone tissue engineering. Nat Med (1995) 1.05
Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol (1993) 1.05
The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry (1991) 1.05
Schilder's disease. Sex-linked recessive transmission with specific adrenal changes. Arch Neurol (1972) 1.05
Injectable biodegradable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-dimethacrylate. Biomaterials (2000) 1.05
In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres. J Biomed Mater Res A (2009) 1.05
Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds. Biomaterials (1999) 1.05
In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mater Res (1999) 1.04
Force-deflection properties of superelastic nickel-titanium archwires. Am J Orthod Dentofacial Orthop (2001) 1.04
Bond strength of self-etching primers to enamel and dentin of primary teeth. Pediatr Dent (2002) 1.03
Platelet adhesion on a bioresorbable poly(propylene fumarate-co-ethylene glycol) copolymer. Biomaterials (1999) 1.03
Animal models for cartilage reconstruction. Biomaterials (2004) 1.03
Biodegradable polymer scaffolds for cartilage tissue engineering. Clin Orthop Relat Res (2001) 1.03
Ultrastructural changes associated with retroviral replication in central nervous system capillary endothelial cells. Lab Invest (1987) 1.02
Effect of finishing and polishing procedures on the surface roughness of packable composites. Oper Dent (2001) 1.02
Retroperitoneal ganglioneuroblastoma: a kaleidoscope of neuronal degeneration. A light and electron microscopic study. J Neuropathol Exp Neurol (1976) 1.01
Synthesis of poly(propylene fumarate) by acylation of propylene glycol in the presence of a proton scavenger. J Biomater Sci Polym Ed (1999) 1.01
Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res (1994) 1.00
Acute multiple sclerosis. Confirmation of "paramyxovirus-like" intranuclear inclusions. Arch Neurol (1974) 1.00
The testis in adreno-leukodystrophy. Am J Pathol (1981) 1.00
Central pontine myelinolysis. An ultrastructural and elemental study. J Neurol Sci (1976) 1.00
Recent progress in gene delivery using non-viral transfer complexes. J Control Release (2001) 1.00
Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol (2001) 0.99
Fabrication of pliable biodegradable polymer foams to engineer soft tissues. Cell Transplant (1997) 0.99
Induction of experimental allergic neuritis with a peptide from myelin P2 basic protein. Nature (1977) 0.99
Mechanical properties of a biodegradable bone regeneration scaffold. J Biomech Eng (2000) 0.99
Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. J Neuroimmunol (1997) 0.98
In vitro degradation of porous poly(L-lactic acid) foams. Biomaterials (2000) 0.98
Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J Biomed Mater Res (2000) 0.97